Host methylation predicts SARS-CoV-2 infection and clinical outcome

preprint OA: gold CC-BY-4.0
📄 Open PDF Full text JSON View at publisher

Abstract

Since the onset of the SARS-CoV-2 pandemic, most clinical testing has focused on RT-PCR. Host epigenome manipulation post coronavirus infection suggests that DNA methylation signatures may differentiate patients with SARS-CoV-2 infection from uninfected individuals, and help predict COVID-19 disease severity, even at initial presentation. We customized Illumina’s Infinium Methylation EPIC array to enhance immune response detection and profiled peripheral blood samples from 164 COVID-19 patients with longitudinal measurements of disease severity and 296 patient controls. Epigenome-wide association analysis revealed 13,033 genome-wide significant methylation sites for case-vs-control status. Genes and pathways involved in interferon signaling and viral response were significantly enriched among differentially methylated sites. We observe highly significant associations at genes previously reported in genetic association studies (e.g. IRF7, OAS1). Using machine learning techniques, models built using sparse regression yielded highly predictive findings: cross-validated best fit AUC was 93.6% for case-vs-control status, and 79.1%, 80.8%, and 84.4% for hospitalization, ICU admission, and progression to death, respectively. In summary, the strong COVID-19-specific epigenetic signature in peripheral blood driven by key immune related pathways related to infection status, disease severity, and clinical deterioration provides insights useful for diagnosis and prognosis of patients with viral infections.
Full text 25,941 characters · extracted from preprint-html · click to expand
Host methylation predicts SARS-CoV-2 infection and clinical outcome | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Host methylation predicts SARS-CoV-2 infection and clinical outcome Iain R. Konigsberg, Bret Barnes, Monica Campbell, Elizabeth Davidson, and 27 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-334297/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Since the onset of the SARS-CoV-2 pandemic, most clinical testing has focused on RT-PCR. Host epigenome manipulation post coronavirus infection suggests that DNA methylation signatures may differentiate patients with SARS-CoV-2 infection from uninfected individuals, and help predict COVID-19 disease severity, even at initial presentation. We customized Illumina’s Infinium Methylation EPIC array to enhance immune response detection and profiled peripheral blood samples from 164 COVID-19 patients with longitudinal measurements of disease severity and 296 patient controls. Epigenome-wide association analysis revealed 13,033 genome-wide significant methylation sites for case-vs-control status. Genes and pathways involved in interferon signaling and viral response were significantly enriched among differentially methylated sites. We observe highly significant associations at genes previously reported in genetic association studies (e.g. IRF7, OAS1). Using machine learning techniques, models built using sparse regression yielded highly predictive findings: cross-validated best fit AUC was 93.6% for case-vs-control status, and 79.1%, 80.8%, and 84.4% for hospitalization, ICU admission, and progression to death, respectively. In summary, the strong COVID-19-specific epigenetic signature in peripheral blood driven by key immune related pathways related to infection status, disease severity, and clinical deterioration provides insights useful for diagnosis and prognosis of patients with viral infections. Epigenetics & Genomics Bioinformatics Personalized Medicine Translational Medicine SARS-CoV-2 COVID-19 epigenetics disease severity predictive classifier precision medicine Figures Figure 1 Figure 2 Figure 3 Figure 4 Full Text Due to technical limitations, full-text HTML conversion of this manuscript could not be completed. However, the latest manuscript can be downloaded and accessed as a PDF. Supplementary Files SupplementaryTable1COVIDvsControlsSignificantAssociations.csv SupplementaryTable1_COVIDvsControls_SignificantAssociations SupplementaryTable2COVIDvsRespInfectionSignificantAssociations.csv SupplementaryTable2_COVIDvsRespInfection_SignificantAssociations SupplementaryTable3RespInfectionvsControlsSignificantAssociations.csv SupplementaryTable3_RespInfectionvsControls_SignificantAssociations SupplementaryTable4COVICprobes.csv SupplementaryTable4_COVICprobes Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-334297","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":16918497,"identity":"51b0c7ef-d4f2-41b7-9dcd-7ce6954e0a2f","order_by":0,"name":"Iain R. Konigsberg","email":"","orcid":"","institution":"University of Colorado ","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Iain","middleName":"R.","lastName":"Konigsberg","suffix":""},{"id":16918498,"identity":"cc078bcf-6329-42de-bd76-54ad00a2c041","order_by":1,"name":"Bret Barnes","email":"","orcid":"","institution":"Illumina","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Bret","middleName":"","lastName":"Barnes","suffix":""},{"id":16918499,"identity":"d3b9139f-0ca0-4ce8-8b11-a55870ac02c8","order_by":2,"name":"Monica Campbell","email":"","orcid":"","institution":"University of Colorado ","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Monica","middleName":"","lastName":"Campbell","suffix":""},{"id":16918500,"identity":"966a79f4-dfb1-4404-8764-ac24015193ee","order_by":3,"name":"Elizabeth Davidson","email":"","orcid":"","institution":"University of Colorado ","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Elizabeth","middleName":"","lastName":"Davidson","suffix":""},{"id":16918501,"identity":"77e79d5a-718f-4415-a7bb-2c79b85b8509","order_by":4,"name":"Yingfei Zhen","email":"","orcid":"","institution":"University of Colorado ","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Yingfei","middleName":"","lastName":"Zhen","suffix":""},{"id":16918502,"identity":"8f12bc93-9047-41aa-b884-e274cf9d12d9","order_by":5,"name":"Olivia Pallisard","email":"","orcid":"","institution":"University of Colorado ","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Olivia","middleName":"","lastName":"Pallisard","suffix":""},{"id":16918503,"identity":"0421795e-68dd-404a-9cb4-d6a87d622fd2","order_by":6,"name":"Meher Boorgula","email":"","orcid":"","institution":"University of Colorado ","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Meher","middleName":"","lastName":"Boorgula","suffix":""},{"id":16918504,"identity":"cffdb6fa-810e-46e5-9122-ec6332c9807a","order_by":7,"name":"Corey Cox","email":"","orcid":"","institution":"University of Colorado ","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Corey","middleName":"","lastName":"Cox","suffix":""},{"id":16918505,"identity":"a4437f4c-aa27-425f-9f2b-bd5dfe5130f9","order_by":8,"name":"Debmalya Nandy","email":"","orcid":"","institution":"University of Colorado ","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Debmalya","middleName":"","lastName":"Nandy","suffix":""},{"id":16918506,"identity":"54babe61-9e58-4f29-be1d-671c4d3a5c43","order_by":9,"name":"Souvik Seal","email":"","orcid":"","institution":"University of Colorado ","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Souvik","middleName":"","lastName":"Seal","suffix":""},{"id":16918507,"identity":"978f45d7-b701-4cd7-863d-6a342106a64a","order_by":10,"name":"Kristy Crooks","email":"","orcid":"","institution":"University of Colorado ","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Kristy","middleName":"","lastName":"Crooks","suffix":""},{"id":16918508,"identity":"e88ca282-dda8-43f3-bc4a-fe134f170ae5","order_by":11,"name":"Evan Sticca","email":"","orcid":"","institution":"University of Colorado ","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Evan","middleName":"","lastName":"Sticca","suffix":""},{"id":16918509,"identity":"71bf7b7f-6592-4609-a35b-32a44a662884","order_by":12,"name":"Genelle F. Harrison","email":"","orcid":"","institution":"University of Colorado ","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Genelle","middleName":"F.","lastName":"Harrison","suffix":""},{"id":16918510,"identity":"015d13f6-4dcf-4304-9222-974d5ba18fe3","order_by":13,"name":"Andrew Hopkinson","email":"","orcid":"","institution":"University of Colorado ","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Andrew","middleName":"","lastName":"Hopkinson","suffix":""},{"id":16918511,"identity":"9c4b1666-2d46-4a06-bf7b-4562f007e474","order_by":14,"name":"Alexis Vest","email":"","orcid":"","institution":"University of Colorado ","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Alexis","middleName":"","lastName":"Vest","suffix":""},{"id":16918512,"identity":"c795c4f7-d0f2-4a01-b742-d0a76e3536d2","order_by":15,"name":"Cosby G. Arnold","email":"","orcid":"","institution":"University of Colorado ","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Cosby","middleName":"G.","lastName":"Arnold","suffix":""},{"id":16918513,"identity":"e0fa30e4-4f22-4aaa-b347-010d3883ce5c","order_by":16,"name":"Michael G. Kahn","email":"","orcid":"","institution":"University of Colorado ","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Michael","middleName":"G.","lastName":"Kahn","suffix":""},{"id":16918514,"identity":"a71a3577-f8d3-4d97-9676-d9a1a75c14ff","order_by":17,"name":"David P. Kao","email":"","orcid":"","institution":"University of Colorado ","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"David","middleName":"P.","lastName":"Kao","suffix":""},{"id":16918515,"identity":"fd0f04f5-b2fe-481b-9200-fc44780c692c","order_by":18,"name":"Brett R. Peterson","email":"","orcid":"","institution":"University of Colorado ","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Brett","middleName":"R.","lastName":"Peterson","suffix":""},{"id":16918516,"identity":"c2b73351-5dc2-4977-b9da-6b4ee4728069","order_by":19,"name":"Stephen J. Wicks","email":"","orcid":"","institution":"University of Colorado ","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Stephen","middleName":"J.","lastName":"Wicks","suffix":""},{"id":16918517,"identity":"d97b4722-ba40-4603-8b01-0d6f3c335adf","order_by":20,"name":"Debashis Ghosh","email":"","orcid":"","institution":"University of Colorado ","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Debashis","middleName":"","lastName":"Ghosh","suffix":""},{"id":16918518,"identity":"9f7c6e72-a3de-428f-8250-fde10f9fb961","order_by":21,"name":"Steve Horvath","email":"","orcid":"","institution":"University of California Los Angeles ","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Steve","middleName":"","lastName":"Horvath","suffix":""},{"id":16918519,"identity":"15dd7cdb-3ea4-420b-ad1a-11ea280d9448","order_by":22,"name":"Wanding Zhou","email":"","orcid":"","institution":"University of Pennsylvania ","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Wanding","middleName":"","lastName":"Zhou","suffix":""},{"id":16918520,"identity":"3c0ffcbc-fac7-46fc-a111-26ddc6ef844f","order_by":23,"name":"Rasika A. Mathias","email":"","orcid":"","institution":"Johns Hopkins University","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Rasika","middleName":"A.","lastName":"Mathias","suffix":""},{"id":16918521,"identity":"72398b0b-ea0c-40e0-91e8-163be4d44f5c","order_by":24,"name":"Paul J. Norman","email":"","orcid":"","institution":"University of Colorado","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Paul","middleName":"J.","lastName":"Norman","suffix":""},{"id":16918522,"identity":"809072ef-d8ba-431b-99f6-b0dd0960632c","order_by":25,"name":"Rishi Porecha","email":"","orcid":"","institution":"Illumina","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Rishi","middleName":"","lastName":"Porecha","suffix":""},{"id":16918523,"identity":"015a8f0d-13b2-4802-aafd-64a7459e3187","order_by":26,"name":"Ivana V. Yang","email":"","orcid":"","institution":"University of Colorado","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Ivana","middleName":"V.","lastName":"Yang","suffix":""},{"id":16918524,"identity":"52e6711e-45b7-488f-ba43-60b3590d7e01","order_by":27,"name":"Christopher R. Gignoux","email":"","orcid":"","institution":"University of Colorado","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Christopher","middleName":"R.","lastName":"Gignoux","suffix":""},{"id":16918525,"identity":"0e38cf90-e6fe-4dbc-aa7d-c29a0ba124ee","order_by":28,"name":"Andrew Monte","email":"","orcid":"","institution":"University of Colorado","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Andrew","middleName":"","lastName":"Monte","suffix":""},{"id":16918526,"identity":"c5d95380-cbba-4418-9df6-8c2df5572bb4","order_by":29,"name":"Alem Taye","email":"","orcid":"","institution":"Illumina","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Alem","middleName":"","lastName":"Taye","suffix":""},{"id":17096105,"identity":"13165107-d95a-43ec-8c69-af058ce0bf8d","order_by":30,"name":"Kathleen C. Barnes","email":"data:image/png;base64,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","orcid":"","institution":"University of Colorado","correspondingAuthor":true,"submittingAuthor":false,"prefix":"","firstName":"Kathleen","middleName":"C.","lastName":"Barnes","suffix":""}],"badges":[],"createdAt":"2021-03-16 16:58:54","currentVersionCode":1,"declarations":{"humanSubjects":true,"vertebrateSubjects":false,"conflictsOfInterestStatement":true,"humanSubjectEthicalGuidelines":true,"humanSubjectConsent":true,"humanSubjectClinicalTrial":false,"humanSubjectCaseReport":false,"vertebrateSubjectEthicalGuidelines":false,"coiExplicitlySet":false},"doi":"10.21203/rs.3.rs-334297/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-334297/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":7241101,"identity":"4cb3a9df-f58b-4161-bf43-11a0e5e4437a","added_by":"auto","created_at":"2021-03-22 20:48:23","extension":"png","order_by":1,"title":"Figure 1","display":"","copyAsset":false,"role":"figure","size":96093,"visible":true,"origin":"","legend":"Flowchart of the study samples.","description":"","filename":"ScreenShot20210322at3.46.51PM.png","url":"https://assets-eu.researchsquare.com/files/rs-334297/v1/13d7bb82fed14a63d5669bbd.png"},{"id":7241103,"identity":"89a1838c-eee3-4a76-9f94-19050dfa76b3","added_by":"auto","created_at":"2021-03-22 20:48:23","extension":"png","order_by":2,"title":"Figure 2","display":"","copyAsset":false,"role":"figure","size":189716,"visible":true,"origin":"","legend":"a, Miami plot (top panel) of hypermethylated (top) and hypomethylated (bottom) probes in SARS-Cov-2+ compared to control samples. Significance lines represent FDR-adjusted P-value \u003c0.05 threshold. b, Volcano plot of significant (red; FDR-adjusted P-value \u003c0.05) CpG sites (blue CpG sites have FDR-adjusted P-value \u003e0.05). Change in % methylation on the x axis represents the difference in average beta value at a site between cases and controls. Probes for intergenic CpG sites do not have gene annotations.","description":"","filename":"ScreenShot20210322at3.46.59PM.png","url":"https://assets-eu.researchsquare.com/files/rs-334297/v1/0a1424b16e7cd3fc1a5505d9.png"},{"id":7241108,"identity":"17b9b8a1-a0a3-4c7a-b683-e835727ba6fe","added_by":"auto","created_at":"2021-03-22 20:48:23","extension":"png","order_by":3,"title":"Figure 3","display":"","copyAsset":false,"role":"figure","size":59933,"visible":true,"origin":"","legend":"Venn diagram of overlaps between COVID-Control EWAS (13,033 significant probes), COVID-viral infection EWAS (516 significant probes), and respiratory infection-\nControl EWAS (1,501 significant probes).","description":"","filename":"ScreenShot20210322at3.47.06PM.png","url":"https://assets-eu.researchsquare.com/files/rs-334297/v1/e610974195cd8eef8659c968.png"},{"id":7241499,"identity":"28226f6d-010f-40d8-817d-c2bdec7c4d74","added_by":"auto","created_at":"2021-03-22 20:51:23","extension":"png","order_by":4,"title":"Figure 4","display":"","copyAsset":false,"role":"figure","size":134184,"visible":true,"origin":"","legend":"a, Out-of-sample case-control methylation score for all 460 individuals compared to\ncase-control status, plotted by biological age. b. Receiver-Operating Characteristic (ROC) Curve\nfor data in a. c, ROC curve of cross-validated prediction of long hospital duration d. Violin and\njittered scatter plots of severity methylation scores for each outcome in cases.","description":"","filename":"ScreenShot20210322at3.47.13PM.png","url":"https://assets-eu.researchsquare.com/files/rs-334297/v1/dd8051b8a3ccc71c1a047b43.png"},{"id":13611569,"identity":"6643770d-e549-4dd6-8032-04fa66e7d204","added_by":"auto","created_at":"2021-09-17 06:29:11","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":1591004,"visible":true,"origin":"","legend":"","description":"","filename":"Konigsbergetal2021COVID19Epigeneticsmanuscript022621.pdf","url":"https://assets-eu.researchsquare.com/files/rs-334297/v1_covered.pdf"},{"id":7242482,"identity":"60ca88b6-ec50-464e-a466-2b49dd1a8733","added_by":"auto","created_at":"2021-03-22 20:57:28","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":2039875,"visible":true,"origin":"","legend":"","description":"","filename":"Konigsbergetal2021COVID19Epigeneticsmanuscript022621.pdf","url":"https://assets-eu.researchsquare.com/files/rs-334297/v1_stamped.pdf"},{"id":7241500,"identity":"53ddc83d-c595-42f5-8ebd-2a807148d68e","added_by":"auto","created_at":"2021-03-22 20:51:23","extension":"csv","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":1819716,"visible":true,"origin":"","legend":"SupplementaryTable1_COVIDvsControls_SignificantAssociations","description":"","filename":"SupplementaryTable1COVIDvsControlsSignificantAssociations.csv","url":"https://assets-eu.researchsquare.com/files/rs-334297/v1/cab85aa77242efc0fc2cc03d.csv"},{"id":7241498,"identity":"f178e047-cfed-42cc-9af0-2d8e4727c8ee","added_by":"auto","created_at":"2021-03-22 20:51:23","extension":"csv","order_by":2,"title":"","display":"","copyAsset":false,"role":"supplement","size":206353,"visible":true,"origin":"","legend":"SupplementaryTable2_COVIDvsRespInfection_SignificantAssociations","description":"","filename":"SupplementaryTable2COVIDvsRespInfectionSignificantAssociations.csv","url":"https://assets-eu.researchsquare.com/files/rs-334297/v1/546879cbbee37e0f999dc4c5.csv"},{"id":7241501,"identity":"d6e56420-fc95-4d8a-9ff4-0d60001af131","added_by":"auto","created_at":"2021-03-22 20:51:23","extension":"csv","order_by":3,"title":"","display":"","copyAsset":false,"role":"supplement","size":72501,"visible":true,"origin":"","legend":"SupplementaryTable3_RespInfectionvsControls_SignificantAssociations","description":"","filename":"SupplementaryTable3RespInfectionvsControlsSignificantAssociations.csv","url":"https://assets-eu.researchsquare.com/files/rs-334297/v1/34ade49e123514883531517b.csv"},{"id":7242043,"identity":"04338e99-7761-4998-a12e-b9d1c962f39d","added_by":"auto","created_at":"2021-03-22 20:54:23","extension":"csv","order_by":4,"title":"","display":"","copyAsset":false,"role":"supplement","size":707478,"visible":true,"origin":"","legend":"SupplementaryTable4_COVICprobes","description":"","filename":"SupplementaryTable4COVICprobes.csv","url":"https://assets-eu.researchsquare.com/files/rs-334297/v1/9d6ac469967d75b5fb8e10e7.csv"}],"financialInterests":"","formattedTitle":"\u003cp\u003eHost methylation predicts SARS-CoV-2 infection and clinical outcome\u003c/p\u003e","fulltext":[{"header":"Full Text","content":"Due to technical limitations, full-text HTML conversion of this manuscript could not be completed. However, the latest manuscript can be downloaded and \u003ca href='/article/rs-334297/latest.pdf' target='_blank'\u003e accessed as a PDF.\u003c/a\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":true,"highlight":"","institution":"University of Colorado Anschutz Medical Campus","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"SARS-CoV-2, COVID-19, epigenetics, disease severity, predictive classifier, precision medicine","lastPublishedDoi":"10.21203/rs.3.rs-334297/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-334297/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eSince the onset of the SARS-CoV-2 pandemic, most clinical testing has focused on RT-PCR. Host epigenome manipulation post coronavirus infection suggests that DNA methylation signatures may differentiate patients with SARS-CoV-2 infection from uninfected individuals, and help predict COVID-19 disease severity, even at initial presentation. We customized Illumina’s Infinium Methylation EPIC array to enhance immune response detection and profiled peripheral blood samples from 164 COVID-19 patients with longitudinal measurements of disease severity and 296 patient controls. Epigenome-wide association analysis revealed 13,033 genome-wide significant methylation sites for case-vs-control status. Genes and pathways involved in interferon signaling and viral response were significantly enriched among differentially methylated sites. We observe highly significant associations at genes previously reported in genetic association studies (e.g. IRF7, OAS1). Using machine learning techniques, models built using sparse regression yielded highly predictive findings: cross-validated best fit AUC was 93.6% for case-vs-control status, and 79.1%, 80.8%, and 84.4% for hospitalization, ICU admission, and progression to death, respectively. In summary, the strong COVID-19-specific epigenetic signature in peripheral blood driven by key immune related pathways related to infection status, disease severity, and clinical deterioration provides insights useful for diagnosis and prognosis of patients with viral infections.\u003c/p\u003e","manuscriptTitle":"Host methylation predicts SARS-CoV-2 infection and clinical outcome","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2021-03-22 20:48:21","doi":"10.21203/rs.3.rs-334297/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"6b4a150a-ec06-4a35-930e-183c704358d4","owner":[],"postedDate":"March 22nd, 2021","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[{"id":3040991,"name":"Epigenetics \u0026 Genomics"},{"id":3040992,"name":"Bioinformatics"},{"id":3040993,"name":"Personalized Medicine"},{"id":3040994,"name":"Translational Medicine"}],"tags":[],"updatedAt":"2021-03-22T20:48:21+00:00","versionOfRecord":[],"versionCreatedAt":"2021-03-22 20:48:21","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-334297","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-334297","identity":"rs-334297","version":["v1"]},"buildId":"uwybb5PU2iWlRI8EIam5Y","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

crossref
last seen: 2026-05-20T01:00:07.048463+00:00
europepmc
last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall
last seen: 2026-05-21T05:10:58.409756+00:00
License: CC-BY-4.0